What is the standard adult dose of temazepam for insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Standard Dose for Temazepam

The standard adult dose of temazepam for insomnia is 15 mg taken 30 minutes before bedtime. 1, 2

Dosing Algorithm

Initial Dosing

  • Standard adults: Start with 15 mg at bedtime 2
  • Elderly or debilitated patients: Start with 7.5 mg at bedtime 2
  • Transient insomnia: 7.5 mg may be sufficient to improve sleep latency 2, 3

Dose Adjustment

  • Some patients may require 30 mg if 15 mg is insufficient 2
  • The FDA-approved dosing range is 7.5-30 mg 2
  • Dose should be taken 30 minutes before retiring 2

Evidence Base

The 2017 American Academy of Sleep Medicine clinical practice guideline specifically recommends temazepam based on trials using 15 mg doses for both sleep onset and sleep maintenance insomnia 1. This represents a WEAK recommendation with moderate quality evidence showing benefits outweigh harms 1.

Key Supporting Data

The guideline's meta-analysis of temazepam 15 mg demonstrated:

  • Clinically significant reduction in subjective sleep latency 1
  • Clinically significant improvement in total sleep time 1
  • Significant reduction in wake after sleep onset (based on limited data) 1
  • Minimal treatment-emergent adverse events 1

While temazepam 30 mg showed efficacy in individual studies, meta-analysis was only possible for the 15 mg dose, making it the evidence-based standard 1.

Important Clinical Considerations

Pharmacokinetics

  • Peak plasma levels occur at 1.2-1.6 hours after dosing 2
  • Half-life of 10-15 hours 4
  • Steady-state achieved by the third dose 2
  • No evidence of enzyme induction with chronic use 2

Safety Profile

Temazepam demonstrates a favorable safety profile in older adults over 8 weeks of treatment, with adverse effects being infrequent (7.8% of patients), mild in severity, and decreasing over time 5. However, recent pharmacovigilance data identified potential signals for ocular toxicities (eye irritation, increased intraocular pressure, glaucoma), behavioral effects (aggression, amnesia), and parasomnias (nightmares, somnambulism) that warrant monitoring 6.

Tapering for Discontinuation

To reduce withdrawal risk, use gradual taper when discontinuing. If withdrawal reactions develop, pause the taper or increase to the previous dose level, then decrease more slowly 2.

Common Pitfall

Unlike faster-acting Z-drugs, temazepam's slower absorption (peak at 1.5 hours) means it may be less effective for sleep onset compared to sleep maintenance 4. For patients with predominantly sleep-onset insomnia, consider alternative agents or ensure adequate time between dosing and attempting sleep.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.